Imaging Vascular Disease and Amyloid in the Aging Brain: Implications for Treatment.

作者: William J Jagust , Sylvia Villeneuve

DOI: 10.14283/JPAD.2015.47

关键词:

摘要: Vascular risk factors (e.g. hypertension, dyslipidemia and diabetes) are well known for Alzheimer' disease. These vascular lead to brain injuries, which also increase the likelihood of dementia. The advent amyloid PET imaging has helped establish that Alzheimer's disease via pathways independent from at least, when injuries measured as white matter lesions infarcts. While (white infarcts) do not seem influence pathology, some evidence suggests increased is related burden. Furthermore, while have an additive impact on integrity, might potentiate cortical thickness regions vulnerable New research should further explore confirm, or refute, possible interactions between integrity cognition. Neuroimaging tools used assess be expanded. Measuring blood flow damage capillary system might, instance, give insight about how can associated burden impact. findings stress need monitoring in midlife a strategy prevention.

参考文章(61)
Keith A. Johnson, Steven M. Greenberg, M. Edip Gurol, Anand Viswanathan, Christopher Gidicsin, Trey Hedden, Sergi Martinez-Ramirez, Andrew Dumas, Anastasia Vashkevich, Alison M. Ayres, Eitan Auriel, Ellis van Etten, Alex Becker, Jeremy Carmasin, Kristin Schwab, Jonathan Rosand, Cerebral amyloid angiopathy burden associated with leukoaraiosis: A positron emission tomography/magnetic resonance imaging study Annals of Neurology. ,vol. 73, pp. 529- 536 ,(2013) , 10.1002/ANA.23830
Lidia Glodzik, Catherine Randall, Henry Rusinek, Mony J. de Leon, Cerebrovascular reactivity to carbon dioxide in Alzheimer's disease. Journal of Alzheimer's Disease. ,vol. 35, pp. 427- 440 ,(2013) , 10.3233/JAD-122011
R. A. Sperling, C. R. Jack, P. S. Aisen, Testing the Right Target and Right Drug at the Right Stage Science Translational Medicine. ,vol. 3, ,(2011) , 10.1126/SCITRANSLMED.3002609
David A. Snowdon, Brain Infarction and the Clinical Expression of Alzheimer Disease-Reply JAMA: The Journal of the American Medical Association. ,vol. 278, pp. 114- 114 ,(1997) , 10.1001/JAMA.1997.03550020046024
Natalie L. Marchant, Bruce R. Reed, Charles S. DeCarli, Cindee M. Madison, Michael W. Weiner, Helena C. Chui, William J. Jagust, Cerebrovascular disease, beta-amyloid and cognition in aging Neurobiology of Aging. ,vol. 33, pp. 1006- ,(2012) , 10.1016/J.NEUROBIOLAGING.2011.10.001
Byoung Seok Ye, Sang Won Seo, Geon Ha Kim, Young Noh, Hanna Cho, Cindy W Yoon, Hee Jin Kim, Juhee Chin, Seun Jeon, Jong Min Lee, Joon-Kyung Seong, Jae Seung Kim, Jae-Hong Lee, Yearn Seong Choe, Kyung Han Lee, Young H Sohn, Michael Ewers, Michael Weiner, Duk L Na, None, Amyloid burden, cerebrovascular disease, brain atrophy, and cognition in cognitively impaired patients Alzheimers & Dementia. ,vol. 11, pp. 494- 503 ,(2015) , 10.1016/J.JALZ.2014.04.521
M. Wirth, S. Villeneuve, R. La Joie, S. M. Marks, W. J. Jagust, Gene–Environment Interactions: Lifetime Cognitive Activity, APOE Genotype, and Beta-Amyloid Burden The Journal of Neuroscience. ,vol. 34, pp. 8612- 8617 ,(2014) , 10.1523/JNEUROSCI.4612-13.2014
Raj N. Kalaria, Rufus Akinyemi, Masafumi Ihara, Does vascular pathology contribute to Alzheimer changes Journal of the Neurological Sciences. ,vol. 322, pp. 141- 147 ,(2012) , 10.1016/J.JNS.2012.07.032
Qingguang Jiang, CY Daniel Lee, Shweta Mandrekar, Brandy Wilkinson, Paige Cramer, Noam Zelcer, Karen Mann, Bruce Lamb, Timothy M Willson, Jon L Collins, Jill C Richardson, Jonathan D Smith, Thomas A Comery, David Riddell, David M Holtzman, Peter Tontonoz, Gary E Landreth, None, ApoE Promotes the Proteolytic Degradation of Aβ Neuron. ,vol. 58, pp. 681- 693 ,(2008) , 10.1016/J.NEURON.2008.04.010
David A. Snowdon, Brain Infarction and the Clinical Expression of Alzheimer DiseaseThe Nun Study JAMA: The Journal of the American Medical Association. ,vol. 277, pp. 813- 817 ,(1997) , 10.1001/JAMA.1997.03540340047031